Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JG.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.28NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.3.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.12NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.4.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FU.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.10NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.1.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.9.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.13NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GY.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.1.4NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.4.1.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GY.7NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FU.5NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.16NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.1.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.16.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.15.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JF.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDANUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.8NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JG.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.6NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.1.5.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JF.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.14NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDP.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HK.3.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
JG.3.2NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
HV.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
KB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDVNUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XDV.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
LR.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
EG.5.1.19NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.13NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
GB.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FY.2.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.11NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
FL.4.1.1NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
XBB.1.5.67NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-18526.8US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used